176 related articles for article (PubMed ID: 18164420)
1. Breast metastasis by medullary thyroid carcinoma detected by FDG positron emission tomography.
Nofech-Mozes S; Mackenzie R; Kahn HJ; Ehrlich L; Raphael SJ
Ann Diagn Pathol; 2008 Feb; 12(1):67-71. PubMed ID: 18164420
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography (18FDG-PET) in the detection of medullary thyroid carcinoma metastases.
Mucha SA; Kunert-Radek J; Pomorski L
Endokrynol Pol; 2006; 57(4):452-5. PubMed ID: 17006852
[TBL] [Abstract][Full Text] [Related]
3. Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging.
Marzola MC; Pelizzo MR; Ferdeghini M; Toniato A; Massaro A; Ambrosini V; Fanti S; Gross MD; Al-Nahhas A; Rubello D
Eur J Surg Oncol; 2010 Apr; 36(4):414-21. PubMed ID: 20100647
[TBL] [Abstract][Full Text] [Related]
4. The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study.
Rubello D; Rampin L; Nanni C; Banti E; Ferdeghini M; Fanti S; Al-Nahhas A; Gross MD
Eur J Surg Oncol; 2008 May; 34(5):581-6. PubMed ID: 17892923
[TBL] [Abstract][Full Text] [Related]
5. Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.
Faggiano A; Grimaldi F; Pezzullo L; Chiofalo MG; Caracò C; Mozzillo N; Angeletti G; Santeusanio F; Lombardi G; Colao A; Avenia N; Ferolla P
Endocr Relat Cancer; 2009 Mar; 16(1):225-31. PubMed ID: 19004986
[TBL] [Abstract][Full Text] [Related]
6. [FDG PET scan of metastases in recurrent medullary carcinoma of the thyroid gland].
Szakáll S; Bajzik G; Repa I; Miklovicz T; Dabasi G; Sinkovics I; Esik O
Orv Hetil; 2002 May; 143(21 Suppl 3):1280-3. PubMed ID: 12077916
[TBL] [Abstract][Full Text] [Related]
7. F-18 FDG PET detection of a medullary thyroid carcinoma in a patient with metastatic colonic cancer; literature review.
Cohen R; Bihan H; des Guetz G; Wind P; Martin A
Ann Endocrinol (Paris); 2009 Dec; 70(6):468-72. PubMed ID: 19744643
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma.
Beuthien-Baumann B; Strumpf A; Zessin J; Bredow J; Kotzerke J
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1604-9. PubMed ID: 17435996
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma.
Szakáll S; Esik O; Bajzik G; Repa I; Dabasi G; Sinkovics I; Agoston P; Trón L
J Nucl Med; 2002 Jan; 43(1):66-71. PubMed ID: 11801705
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma eats medullary thyroid carcinoma, a case of tumor-in-tumor metastasis.
Sung TY; Lee SR; Lee JH; Lee YM; Lee AL; Hwang DW; Yoon JH; Gong G; Hong SJ; Park KM
Endocr J; 2011; 58(9):801-5. PubMed ID: 21757828
[TBL] [Abstract][Full Text] [Related]
11. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
12. Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas.
Khan N; Oriuchi N; Higuchi T; Endo K
Cancer Control; 2005 Oct; 12(4):254-60. PubMed ID: 16258498
[TBL] [Abstract][Full Text] [Related]
13. How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non-18F-FDG PET radiopharmaceuticals.
Wong KK; Laird AM; Moubayed A; Chondrogiannis S; Marzola MC; Evangelista L; Gross MD; Rubello D
Nucl Med Commun; 2012 Jul; 33(7):679-88. PubMed ID: 22422100
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.
Oudoux A; Salaun PY; Bournaud C; Campion L; Ansquer C; Rousseau C; Bardet S; Borson-Chazot F; Vuillez JP; Murat A; Mirallié E; Barbet J; Goldenberg DM; Chatal JF; Kraeber-Bodéré F
J Clin Endocrinol Metab; 2007 Dec; 92(12):4590-7. PubMed ID: 17878252
[TBL] [Abstract][Full Text] [Related]
15. Unilateral solitary breast metastasis from medullary carcinoma of thyroid detected by FDG-PET.
Basu S; Shet T
Clin Nucl Med; 2010 Jul; 35(7):512-3. PubMed ID: 20548144
[No Abstract] [Full Text] [Related]
16. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
Giraudet AL; Vanel D; Leboulleux S; Aupérin A; Dromain C; Chami L; Ny Tovo N; Lumbroso J; Lassau N; Bonniaud G; Hartl D; Travagli JP; Baudin E; Schlumberger M
J Clin Endocrinol Metab; 2007 Nov; 92(11):4185-90. PubMed ID: 17726071
[TBL] [Abstract][Full Text] [Related]
17. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Leboeuf R; Bénard F; Langlois MF
Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803
[TBL] [Abstract][Full Text] [Related]
18. Role of PET in medullary thyroid carcinoma.
Rufini V; Treglia G; Perotti G; Leccisotti L; Calcagni ML; Rubello D
Minerva Endocrinol; 2008 Jun; 33(2):67-73. PubMed ID: 18388854
[TBL] [Abstract][Full Text] [Related]
19. Early distant relapse in early stage triple-negative breast cancer: usefulness of FDG-PET for diagnosis of distant metastases.
Hama Y; Nakagawa K
Breast Cancer; 2013 Apr; 20(2):191-3. PubMed ID: 20082162
[TBL] [Abstract][Full Text] [Related]
20. Radioguided hepatic resection with
López-Gómez J; Medina-Ornelas S; Salazar-Álvarez MA; Álvarez-Bojórquez M; Zaragoza-Cruz N; Melchor-Ruan J; Álvarez-Cano A
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(4):244-249. PubMed ID: 29754940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
